EMI for Reducing Psychological Distress in Young Adults With Multiple ACEs: A Feasibility Study
2026年9月15日 更新者：Yinyin Zang, PhD、Peking University
Ecological Momentary Intervention for Reducing Psychological Distress in Young Adults With Multiple Adverse Childhood Experiences: A Feasibility Study
This single-arm feasibility study aims to evaluate the feasibility and acceptability of an ecological momentary intervention (EMI) designed to reduce psychological distress among young adults with high levels of adverse childhood experiences (ACEs).
The intervention targets three potentially modifiable transdiagnostic psychological processes: emotional clarity, self-esteem, and catastrophizing.
Approximately 20 young adults aged 18-29 years who have experienced at least two types of ACEs and report elevated psychological distress will be enrolled.
All participants will receive a 2-week smartphone-based EMI delivered in daily life.
Feasibility, acceptability, and safety will be evaluated using recruitment, retention, intervention use, participant satisfaction, perceived burden, and adverse events.
Changes in psychological distress and related psychological outcomes from baseline to post-intervention will also be explored as exploratory outcomes.
調査の概要
研究の種類
介入
入学 (推定)
20
段階
- 適用できない
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究連絡先
- 名前：Yinyin Zang
- 電話番号：010-62756953
- メール：Yinyin.Zang@pku.edu.cn
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
- 大人
健康ボランティアの受け入れ
いいえ
説明
Inclusion Criteria:
- Aged 18-29 years.
- History of relatively high exposure to adverse childhood experiences (ACEs), defined as having experienced at least two types of ACEs.
- Presence of psychological distress, defined as a score of 5 or higher on the 6-item Kessler Psychological Distress Scale (K6).
- Able to read and understand Chinese fluently.
- Owns a smartphone with reliable internet access and is able to perform basic smartphone operations.
- Willing to participate in the study and provide informed consent.
Exclusion Criteria:
- Current or previous diagnosis of a mental disorder by a psychiatrist.
- High suicide risk as assessed using the self-report screening version of the Columbia-Suicide Severity Rating Scale (C-SSRS).
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：なし
- 介入モデル：単一グループの割り当て
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：EMI intervention
EMI intervention targets three potentially modifiable transdiagnostic psychological processes: emotional clarity, self-esteem, and catastrophizing.
The intervention includes brief ecological momentary assessments and tailored exercises addressing negative and positive emotional experiences.
|
The ecological momentary intervention (EMI) is a 2-week smartphone-based intervention delivered in participants' daily lives. At the beginning of the intervention, participants will watch an approximately 10-minute psychoeducational video introducing the psychological principles underlying the intervention and the purposes of the exercises. They will then receive instructions on how to use the EMI program. During the intervention period, participants will receive brief ecological momentary assessments (EMAs) assessing their current emotional state. Based on their reported emotional valence, the program will provide tailored intervention content. When participants report negative or neutral emotional states (emotional valence ≤ 0), they will receive a negative-emotion module. This module includes brief breathing and grounding exercises, identification and labeling of current emotions, identification of potentially catastrophic or negative self-referential thoughts, cognitive reapprais |
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Enrollment Rate Among Eligible Participants
時間枠：Through completion of recruitment, up to 3 weeks
|
The proportion of eligible individuals who enroll in the study will be calculated as the number of enrolled participants divided by the total number of eligible participants, multiplied by 100.
|
Through completion of recruitment, up to 3 weeks
|
|
Proportion of Eligible Participants
時間枠：Through completion of recruitment, up to 3 weeks
|
The proportion of screened individuals who meet the study eligibility criteria will be calculated as the number of eligible participants divided by the total number of individuals screened, multiplied by 100.
|
Through completion of recruitment, up to 3 weeks
|
|
Intervention Engagement
時間枠：Throughout the 2-week intervention
|
Intervention engagement will be assessed using automatically recorded program-use data, including participants' completion of ecological momentary assessments and intervention exercises during the intervention period.
The proportion of delivered intervention opportunities that are completed will be summarized.
|
Throughout the 2-week intervention
|
|
Study Retention Rate
時間枠：Immediately post-treatment
|
Study retention will be assessed as the proportion of enrolled participants who complete the post-intervention assessment.
|
Immediately post-treatment
|
|
Intervention acceptability
時間枠：Immediately post-treatment
|
Intervention acceptability will be assessed using an adapted version of the Chinese Acceptability of Intervention Measure (cAIM).
In addition to the original cAIM items, the adapted measure includes items assessing participants' willingness to recommend the intervention to friends and their willingness to continue using the intervention, informed by Wang et al. (2024).
All items are rated on a 5-point scale from 1 (completely disagree) to 5 (completely agree), with higher scores indicating greater perceived acceptability of the intervention.
|
Immediately post-treatment
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Psychological Distress
時間枠：Baseline and immediately post-treatment
|
Psychological distress will be assessed using the 6-item Kessler Psychological Distress Scale (K6).
Each item is rated on a 5-point frequency scale from 0 to 4. Item scores are summed to produce a total score ranging from 0 to 24, with higher scores indicating greater psychological distress.
|
Baseline and immediately post-treatment
|
|
Catastrophizing
時間枠：Baseline and immediately post-treatment
|
Catastrophizing will be assessed using the catastrophizing subscale of the 18-item Cognitive Emotion Regulation Questionnaire (CERQ-18).
The CERQ-18 consists of nine 2-item subscales.
Each item is rated on a 5-point scale from 1 to 5. The two catastrophizing items are summed to produce a subscale score ranging from 2 to 10, with higher scores indicating more frequent use of catastrophizing as a cognitive emotion regulation strategy.
|
Baseline and immediately post-treatment
|
|
Self-Esteem
時間枠：Baseline and immediately post-treatment
|
Global self-esteem will be assessed using the 10-item Rosenberg Self-Esteem Scale (RSES).
Each item is rated on a 4-point scale from 1 to 4, with negatively worded items reverse-scored.
Item scores are summed to produce a total score ranging from 10 to 40, with higher scores indicating higher levels of global self-esteem.
|
Baseline and immediately post-treatment
|
|
Emotional clarity
時間枠：Baseline and immediately post-treatment
|
Emotional clarity will be assessed using the Lack of Emotional Clarity subscale of the 18-item Difficulties in Emotion Regulation Scale-Short Form (DERS-SF).
The subscale consists of two items, each rated on a 5-point scale from 1 to 5. Item scores are summed to yield a total score ranging from 2 to 10, with higher scores indicating greater difficulties in emotional clarity.
|
Baseline and immediately post-treatment
|
|
Depressive Symptoms
時間枠：Baseline and immediately post-treatment
|
Depressive symptoms will be assessed using the 9-item Patient Health Questionnaire (PHQ-9).
Each item is rated according to symptom frequency over the preceding 2 weeks on a 4-point scale from 0 (not at all) to 3 (nearly every day).
Item scores are summed to produce a total score ranging from 0 to 27, with higher scores indicating greater severity of depressive symptoms.
|
Baseline and immediately post-treatment
|
|
Anxiety Symptoms
時間枠：Baseline and immediately post-treatment
|
Anxiety symptoms will be assessed using the 7-item Generalized Anxiety Disorder scale (GAD-7).
Each item is rated according to symptom frequency over the preceding 2 weeks on a 4-point scale from 0 (not at all) to 3 (nearly every day).
Item scores are summed to produce a total score ranging from 0 to 21, with higher scores indicating greater severity of anxiety symptoms.
|
Baseline and immediately post-treatment
|
|
Eating Disorder Symptoms
時間枠：Baseline and immediately post-treatment
|
Eating disorder symptoms will be assessed using the 12-item Eating Disorder Examination Questionnaire-Short Form (EDE-QS).
Each item is scored from 0 to 3. Item scores are summed to produce a total score ranging from 0 to 36, with higher scores indicating greater severity of eating disorder symptoms.
|
Baseline and immediately post-treatment
|
|
Insomnia Severity
時間枠：Baseline and immediately post-treatment
|
Insomnia symptoms will be assessed using the 7-item Insomnia Severity Index (ISI).
Each item is rated on a 5-point scale from 0 to 4. Item scores are summed to produce a total score ranging from 0 to 28, with higher scores indicating greater insomnia severity.
|
Baseline and immediately post-treatment
|
|
Somatic Symptom Severity
時間枠：Baseline and immediately post-treatment
|
Somatic symptoms will be assessed using the 15-item Patient Health Questionnaire (PHQ-15).
Each item is rated on a 3-point scale from 0 (not bothered at all) to 2 (bothered a lot).
Item scores are summed to produce a total score ranging from 0 to 30, with higher scores indicating greater somatic symptom severity.
|
Baseline and immediately post-treatment
|
|
Suicidal Ideation
時間枠：Baseline and immediately post-treatment
|
Suicidal ideation will be assessed using the Beck Scale for Suicide Ideation (BSS).
The BSS contains 21 items; the first 19 items assess the severity of current suicidal ideation and are scored from 0 to 2. These 19 items are summed to produce a total score ranging from 0 to 38, with higher scores indicating greater severity of suicidal ideation.
The remaining two items assess previous suicide attempts and are not included in the total severity score.
|
Baseline and immediately post-treatment
|
|
Self-Harm Severity
時間枠：Baseline and immediately post-treatment
|
Self-harm will be assessed using a study-developed self-report questionnaire assessing the severity of self-harm behaviors.
|
Baseline and immediately post-treatment
|
|
Urgency
時間枠：Baseline and immediately post-treatment
|
Negative and positive urgency will be assessed using the Negative Urgency and Positive Urgency subscale of the Short UPPS-P Impulsive Behavior Scale (SUPPS-P), respectively.
Each subscale contains 4 items rated on a 4-point scale from 1 to 4. After appropriate reverse scoring, the four items are summed to produce a score ranging from 4 to 16, with higher scores indicating a greater tendency to act impulsively when experiencing intense emotions.
|
Baseline and immediately post-treatment
|
|
Functional Impairment
時間枠：Baseline and immediately post-treatment
|
Functional impairment will be assessed using the Sheehan Disability Scale (SDS).
The scale contains 3 items assessing impairment in work or school, social life, and family life or home responsibilities.
Each item is rated from 0 to 10.
The three items are summed to produce a total score ranging from 0 to 30, with higher scores indicating greater functional impairment.
|
Baseline and immediately post-treatment
|
|
Life Satisfaction
時間枠：Baseline and immediately post-treatment
|
Life satisfaction will be assessed using the 5-item Satisfaction With Life Scale (SWLS).
Each item is rated on a 7-point scale from 1 to 7. Item scores are summed to produce a total score ranging from 5 to 35, with higher scores indicating greater satisfaction with life.
|
Baseline and immediately post-treatment
|
|
Self-Compassion
時間枠：Baseline and immediately post-treatment
|
Self-compassion will be assessed using the 12-item Self-Compassion Scale-Short Form (SCS-SF).
Each item is rated on a 5-point scale from 1 (almost never) to 5 (almost always).
Negatively worded items are reverse-scored, and an overall mean score ranging from 1 to 5 is calculated, with higher scores indicating greater self-compassion.
|
Baseline and immediately post-treatment
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
スポンサー
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (推定)
2026年9月7日
一次修了 (推定)
2026年10月11日
研究の完了 (推定)
2026年10月11日
試験登録日
最初に提出
2026年9月4日
QC基準を満たした最初の提出物
2026年9月15日
最初の投稿 (実際)
2026年9月16日
学習記録の更新
投稿された最後の更新 (実際)
2026年9月16日
QC基準を満たした最後の更新が送信されました
2026年9月15日
最終確認日
2026年9月1日
詳しくは
本研究に関する用語
その他の研究ID番号
- EMI for high ACEs
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
いいえ
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
いいえ
米国FDA規制機器製品の研究
いいえ
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。